Pfizer tests oral COVID-19 antiviral drug in US trial
Pfizer has begun a US-based Phase 1 study of its investigational
oral antiviral drug PF-07321332 as a treatment for COVID-19. The protease
inhibitor will be given to healthy adults exhibiting the first symptoms of a
coronavirus infection and will be evaluated for its tolerability and safety
during the trial.
Full Story: United
Press International (3/23)
No comments:
Post a Comment